Reactive oxygen species from non-thermal gas plasma (CAP): implication for targeting cancer stem cells.

Autor: Babajani A; Oncopathology Research Center, Iran University of Medical Sciences (IUMS), Tehran, Iran., Eftekharinasab A; Plasma Medicine Group, Plasma Research Institute, Kharazmi University, Tehran, Iran., Bekeschus S; ZIK Plasmatis, Leibniz Institute for Plasma Science and Technology (INP), Felix-Hausdorff-Str. 2, 17489, Greifswald, Germany., Mehdian H; Plasma Medicine Group, Plasma Research Institute, Kharazmi University, Tehran, Iran., Vakhshiteh F; Oncopathology Research Center, Iran University of Medical Sciences (IUMS), Tehran, Iran. f.vakhshiteh@gmail.com., Madjd Z; Oncopathology Research Center, Iran University of Medical Sciences (IUMS), Tehran, Iran. majdjabari.z@iums.ac.ir.; Department of Molecular Medicine, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences (IUMS), Tehran, Iran. majdjabari.z@iums.ac.ir.
Jazyk: angličtina
Zdroj: Cancer cell international [Cancer Cell Int] 2024 Oct 22; Vol. 24 (1), pp. 344. Date of Electronic Publication: 2024 Oct 22.
DOI: 10.1186/s12935-024-03523-x
Abstrakt: Cancer remains a major global health challenge, with the persistence of cancer stem cells (CSCs) contributing to treatment resistance and relapse. Despite advancements in cancer therapy, targeting CSCs presents a significant hurdle. Non-thermal gas plasma, also known as CAP, represents an innovative cancer treatment. It has recently gained attention for its often found to be selective, immunogenic, and potent anti-cancer properties. CAP is composed of a collection of transient, high-energy, and physically and chemically active entities, such as reactive oxygen species (ROS). It is acknowledged that the latter are responsible for a major portion of biomedical CAP effects. The dynamic interplay of CAP-derived ROS and other components contributes to the unique and versatile properties of CAP, enabling it to interact with biological systems and elicit various therapeutic effects, including its potential in cancer treatment. While CAP has shown promise in various cancer types, its application against CSCs is relatively unexplored. This review assesses the potential of CAP as a therapeutic strategy for targeting CSCs, focusing on its ability to regulate cellular states and achieve redox homeostasis. This is done by providing an overview of CSC characteristics and demonstrating recent findings on CAP's efficacy in targeting these cells. By contributing insights into the unique attributes of CSCs and the potential of CAP, this work contributes to an advanced understanding of innovative oncology strategies.
(© 2024. The Author(s).)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje